The Impact of Brexit on Medical Devices and Diagnotics
100+ Total results for product and free and sample content found
Trialtrove: gold standard clinical trials int...
15 Oct 2021
Deep dive into China’s clinical landscape to learn more about the startling growth in clinical research in our whitepaper from Dr Annie Siu, PhD, MBA, APAC - Content Director, Informa Pharma Intelligence and Andrew Benson, MSc - Senior Director, Trialtrove.
15 Oct 2021
Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.
13 Oct 2021
The companies will combine their extensive expertise and data sets to enhance Citeline Study Feasibility and help clinical trial teams accelerate the time to first and last patient in
Topic Clinical Trials
By Sue Sutter 13 Oct 2021
Immune responses to a single booster dose of mRNA-1273 would be considered successfully bridged to the two-dose primary series if each of two immunobridging criteria were met, but the mRNA vaccine missed the prespecified success criteria for seroresponse rate, the FDA said.
12 Oct 2021
Shortlist includes innovators from across pharma and biopharma London, UK – Tuesday 12 October, 2021 – The past year’s top achievements in pharma and biopharma were recognised as Informa Pharma Intelligence unveiled its finalists for the 2021 CPhI Pharma Awards, honouring excellence in Pharma.
By Marion Webb 12 Oct 2021
In this roundup of developments in digital health, we highlight the key news and announcements from August and September.
By Francesca Bruce 12 Oct 2021
The company behind the CVnCOV COVID-19 vaccine candidate says the decision to withdraw from regulatory review is strategic. The EMA says outstanding issues affecting the benefit-risk balance remained to be answered at the time of withdrawal.
By Barnaby Pickering 12 Oct 2021
In a panel discussion at The Medtech Conference, hosted by AdvaMed, CEOs discussed the challenges, benefits and technicalities surrounding an IPO.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: